mHealth Intelligence March 16, 2018
mHealth tools embedded with AI technology are helping doctors and those living with diabetes detect hyperglycemia and hypoglycemia up to an hour ahead of time, averting serious and potentially fatal health issues.
mHealth devices embedded with artificial intelligence are helping people with diabetes identify dangerous changes in their blood sugar levels before they happen, avoiding serious and sometimes fatal consequences.
The U.S. Food and Drug Administration recently approved a stand-alone continuous glucose monitoring (CGM) system, developed by Medtronic, that reports blood sugar readings every five minutes and can detect a user’s trending blood sugar levels up to an hour in advance and send a smartphone alert.
The technology is designed to be used by patients between 14 and 75 years...
Today's Sponsors
Today's Sponsor